A phase II protection study of BB-10010 in patients with high grade non-Hodgkin's lymphoma undergoing intensive chemotherapy.

R. E. Hough, P. C. Lorigan, C. Poynton, A. Newland, R. K. Gupta, J. Foran, B. W. Hancock

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'A phase II protection study of BB-10010 in patients with high grade non-Hodgkin's lymphoma undergoing intensive chemotherapy.'. Together they form a unique fingerprint.

Medicine & Life Sciences